SCHEMBL4101685

SCHEMBL4101685

O=C(NC[C]1CCCCCCC1)c1cc(I)ccc1Cl.[CH2].[CH2]

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
LMNA P02545 3/20 0.42
TP53 P04637 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
P2RX7 Q99572 3/20 0.40
HPGD P15428 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
POLB P06746 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 2/20 0.38
ALOX15 P16050 1/20 0.37
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8081000 0.86 CA1 (0.55) MEN1KMT2ALMNATP53CA1
SCHEMBL7658512 0.85 P2RX7 (0.54) MEN1KMT2ALMNATP53SMN1; SMN2
SCHEMBL7552476 0.84 HPGD (0.54) MEN1KMT2AP2RX7HPGDCYP1A2
SCHEMBL7971490 0.84 NPC1 (0.51) MEN1KMT2ALMNATP53SMN1; SMN2
SCHEMBL7560739 0.84 P2RX7 (0.55) MEN1KMT2ALMNATP53SMN1; SMN2
SCHEMBL5334659 0.83 CYP4F2 (0.46) MEN1KMT2ALMNATP53SMN1; SMN2
SCHEMBL7554542 0.83 EPHX2 (0.49) MEN1KMT2ALMNATP53SMN1; SMN2
SCHEMBL7560196 0.82 MEN1 (0.40) MEN1KMT2ALMNATP53SMN1; SMN2
SCHEMBL7592357 0.80 HPGD (0.54) LMNASMN1; SMN2P2RX7HPGDCYP1A2
SCHEMBL6485285 0.80 P2RX7 (0.53) MEN1KMT2ALMNATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2059497-A1 PROCESS FOR PREPARING N-METHYLADAMANTYL DERIVATIVES BY A PALLADIUM CATALYSED COUPLING REACTION FOLLOWED BY REDUCTIVE AMINATION AstraZeneca AB (SE) 2009-05-20 EP disclosed
WO-2008030160-A1 PROCESS FOR PREPARING N-METHYLADAMANTYL DERIVATIVES BY A PALLADIUM CATALYSED COUPLING REACTION FOLLOWED BY REDUCTIVE AMINATION ASTRAZENECA AB (SE) 2008-03-13 WO disclosed